The role of IL-12p40 in the response of pulmonary dendritic cells to tuberculosis

描述（由申请人提供）：耐多药结核病（TB）的出现威胁到我们控制这种高度传播和致命疾病的能力。美国国立卫生研究院已经认识到这一威胁，PA-04-119的发布鼓励了对结核病自然史有更深入了解的研究。本申请通过研究肺结核免疫应答的一个新方面对PA-04-119做出响应。具体而言，我们首次显示了细胞因子IL-12 p40在结核分枝杆菌（Mtb）诱导的肺树突状细胞（DC）从肺向引流淋巴结（LN）迁移中的作用。我们还表明，在没有这种病原体诱导的迁移的情况下，几乎没有诱导抗原特异性CD 4 T细胞应答，也完全丧失了免疫介导的抗疾病保护。关于IL-12 p40在TB自然史中的作用的这一新观察为研究IL-12 p40介导其对肺DC的作用的机制提供了基础。通过了解这种细胞因子在微生物诱导的DC迁移中的作用，我们将不仅影响TB，而且影响通过肺进入并由CD 4 T细胞介导的免疫应答控制的其他A、B或C类病原体。本提案的目的是检查Mtb在肺内诱导IL-12 p40的途径，并确定IL-12 p40介导Mtb诱导的DC迁移的机制。通过阐明IL-12 p40对DC的作用机制，我们将深入了解Mtb如何调节免疫应答的诱导。在Aim One中，我们将确定肺中哪些细胞需要产生IL-12 p40来响应Mtb，以便发生DC迁移。我们还将确定启动和传播DC迁移所需的受体。在目标二中，我们将确定IL-12 p40能够调节DC响应趋化因子梯度的能力的程度。我们将确定单独的IL-12 p40是否足以介导DC迁移，或者微生物信号是否对该过程至关重要。如果我们确定IL-12 p40能够启动肺DC的迁移，那么将来我们将检查IL-12 p40刺激的DC在肺内启动细胞应答的能力。从长远来看，这可以为基于IL-12 p40的佐剂提供基础，用于通过肺部途径递送的疫苗。这项工作与公共卫生的相关性在于，它将增加我们对身体对细菌入侵的反应的理解。这种理解的增加将允许有针对性的新干预措施，这将提高我们控制疾病的能力。

DESCRIPTION (provided by applicant): The emergence of multi-drug resistant tuberculosis (TB) threatens our ability to control this highly transmissible and deadly disease. The NIH has recognized this threat and research that will result in greater understanding of the natural history of TB has been encouraged by the release of PA-04-119. This application responds to PA-04-119 by investigating a novel aspect of the pulmonary immune response to TB. Specifically, we show for the first time data that demonstrate a role for the cytokine IL-12p40 in the Mycobacterium tuberculosis (Mtb)-induced migration of pulmonary dendritic cells (DC) from the lung to the draining lymph node (LN). We also show that in the absence of this pathogen-induced migration there is little to no induction of an antigen-specific CD4 T cell response and also a complete loss of immune-mediated protection against disease. This novel observation regarding the role of IL-12p40 in the natural history of TB provides a basis for investigation of the mechanisms whereby IL-12p40 mediates its effects on pulmonary DC. By understanding the role of this cytokine in microbially induced DC migration we will impact not only TB but also other class A, B or C pathogens that enter via the lung and are controlled by CD4 T cell-mediated immune responses. The objective of this proposal is to examine the pathway whereby Mtb induces IL-12p40 within the lung and determine the mechanism whereby IL-12p40 mediates the Mtb-induced migration of DC. By elucidating the mechanism of action of IL-12p40 on DC we will gain insight into how Mtb modulates the induction of the immune response. In Aim One we will determine which cells in the lung are required to produce IL-12p40 in response to Mtb in order for DC migration to occur. We will also determine which receptors are required to initiate and propagate the migration of DC. In Aim Two we will determine the extent to which IL-12p40 is capable of modulating the ability of DC to respond to a chemokine gradient. We will determine whether IL-12p40 alone is sufficient to mediate DC migration or whether a microbial signal is essential to this process. If we determine that IL-12p40 is capable of initiating migration of pulmonary DC then in the future we will examine the ability of IL-12p40 stimulated DC to initiate cellular responses within the lung. In the long term this could provide the basis for an IL-12p40 based adjuvant for vaccines delivered via the pulmonary route. The relevance of this work to public health is that it will increase our understanding of the response of the body to bacterial invasion. This increased understanding will allow targeted and novel interventions that will improve our ability to control disease.